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Coccidioidomycosis	among	Prison	Employees,	California
Nevertheless, reducing dust is a reasonable risk-reduction 
strategy for addressing occupational coccidioidomycosis.
On the basis of our findings, we recommended that 
prison management weigh the advantages and disadvan-
tages of various environmental mitigation efforts to reduce 
dust exposures. Our recommendations included providing 
employees with education and training about coccidioido-
mycosis symptoms and transmission, risk factors for dis-
seminated disease, and ways to minimize exposures; closing 
the prison yards during dust storms; and using respirators 
approved by the National Institute for Occupational Safety 
and Health as part of a respiratory protection program for 
employees who must work outside during unusually dusty 
days or who may disturb soil. The recently available coc-
cidioidal spherulin skin test may also be a potentially useful 
tool for identifying at-risk employees.
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A soil fungus found in the western United States and parts of Mexico and Cen-tral and South America, Coccidioides was discovered in 1892 by Alejandro 
Posadas, a medical student, in an Argentinian soldier with widespread disease. 
Biopsy specimens revealed organisms that resembled the protozoan Coccidia 
(from the Greek kokkis, “little berry”). In 1896, Gilchrist and Rixford named 
the organism Coccidioides (“resembling Coccidia”) immitis (Latin for “harsh,” 
describing the clinical course). Ophüls and Moffitt proved that C. immitis was a 
fungus rather than a protozoan in 1900. In 2002, C. immitis was divided into a 
second species, C. posadasii, after Alejandro Posadas.
Photomicrograph	reveals	the	presence	of	 
thick-walled arthroconidia and arthrospores 
of Coccidioides immitis fungal organisms.
